Skip to content

Improving Sleep in the Neurology In-Patient Population

Improving Sleep in the Neurology In-Patient Population

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06094699
Acronym
I_SLEEP
Enrollment
145
Registered
2023-10-23
Start date
2023-04-30
Completion date
2025-07-01
Last updated
2025-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep

Brief summary

We aim to test multiple interventions to improve sleep for Neurology inpatients, including 1) a sleep-friendly order set, and 2) a sleep menu. We will collect patient sleep data, including duration and quality, via actigraphy devices (FitBits). We will also conduct qualitative patient surveys to understand the impact of these interventions.

Interventions

OTHERSleep friendly order set

Every evening, the following orders (which comprise the sleep-friendly order set) will be input into the EMR: Hold vital signs and neurological checks overnight Retime applicable medications outside of the nighttime window of 10pm-6am Retime daily lab draws outside of the nighttime window of 10pm-6am Order melatonin if no clinical contraindications Discontinue finger stick glucose measurements for patients with a stable blood glucose values Change DVT prophylaxis to enoxaparin for all clinically eligible patients

OTHERPatient sleep menu

Patients will be given a menu of non-pharmacological options that support sleep by improving comfort and reducing anxiety.

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 * 24 hours after admission to the general neurology (ward) service at the Hospital of the University of Pennsylvania * Patients who are determined by the primary team to be clinically stable enough to forego serial overnight vital signs monitoring and neuro checks. * Clinical stability criteria: * Symptomatic stability \>24h after admission (no new or progressive neurologic symptoms for \>24 hours) * Vital signs stability on admission for \> 24h while admitted * Ability to verbally consent to study participation

Exclusion criteria

* Any medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's safety or successful participation in the study. * Any additional clinical factors felt by the team to be incompatible with specific orders including requiring serial vital signs monitoring and neuro checks overnight

Design outcomes

Primary

MeasureTime frameDescription
Fitbit Sleep DurationDuration of hospitalization from consent to discharge or day 10, whichever comes firstTotal hours of sleep

Secondary

MeasureTime frameDescription
FitBit sleep scoreDuration of hospitalization from consent to discharge or day 10, whichever comes firstThe sleep score integrates subject sleep deprivation, sleep depth, and sleep restoration
Richard Campbell Sleep Questionnaire (RCSQ)Duration of hospitalization from consent to discharge or day 10, whichever comes firstThe Richards-Campbell Sleep Questionnaire (RCSQ) is a simple, validated survey instrument for measuring sleep quality in intensive care patients
Patient reported Sleep Duration and QualityDuration of hospitalization from consent to discharge or day 10, whichever comes firstA brief survey collecting patient perceived duration and quality of sleep

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026